ArticleNPJ vaccines2024

Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.

Myra Happe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.